In the realm of epidemiology, artificial blood holds significant promise. It can potentially alleviate the burden on blood banks, especially during emergencies like natural disasters, pandemics, or warfare. The use of artificial blood could also reduce risks associated with blood transfusions, such as spreading infectious diseases like HIV, Hepatitis B, and Hepatitis C.
